BMS-986036 Uses, Dosage, Side Effects and more
BMS-986036 is under investigation in clinical trial NCT03486899 (A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis).
| Trade Name | BMS-986036 |
| Generic | Pegbelfermin |
| Pegbelfermin Other Names | BMS-986036, Pegbelfermin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
